Our Projects

Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.

Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.

 

 

Filters / Search

Grant focus
To transform oral HIV treatment into a long-acting injectable

Grantees
University of Washington

Status
Current

Amount
US$ 6,962,027

Disease
HIV and Co-Infection

Long-acting injections to treat HIV

View More

Ajara waits at the ART clinic. She is coinfected with HIV and TB. Image: John Rae / The Global Fund

Grant focus
Enable the scale-up of optimized second-line combination antiretroviral therapy for HIV patients who have failed first-line therapy

Grantees
University of New South Wales (Kirby Institute)

Status
Current

Amount
US$ 9,026,168

Disease
HIV and Co-Infection

Comparing a dolutegravir + darunavir combination to the standard treatment for HIV patients who have failed first-line therapy

View More

Grant focus
Reduce rates of mother-to-child transmission of HIV among women starting antiretroviral treatment in the third trimester of pregnancy

Grantees
University of Liverpool

Status
Current

Amount
US$ 10,924,812

Disease
HIV and Co-Infection

Dolutegravir in pregnant mothers and newborns

View More

Grant focus
Improve antiretroviral treatment for HIV-positive people in low- and middle-income countries

Grantees
Wits Reproductive Health & HIV Institute

Status
Current

Amount
US$ 22,851,279

Disease
HIV and Co-Infection

ADVANCE Trial – A rigorous clinical trial that could yield better first-line HIV treatment

View More

Abidjan - Clinic VIH - patients waiting for their ARVs

Grant focus
Increase access to more tolerable HIV medicines and relevant health products

Grantees
Clinton Health Access Initiative (CHAI)

Status
Complete

Amount
US$ 70,847,904

Disease
HIV and Co-Infection

Accelerating Patient Access to Optimal Antiretrovirals and relevant health products

View More

Grant focus
Generate robust evidence on the clinical and economic benefits of a dolutegravir-based regimen in an African setting

Grantees
Institut Bouisson Bertrand

Status
Current

Amount
US$ 3,261,312

Disease
HIV and Co-Infection

Enabling access to new first-line antiretrovirals in low-income countries

View More

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.